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ABSTRACT

Domestic canines are regarded as natural sentinels for the transmission of vectorborne pathogens since infection in an owner’s dog suggests the presence of the vector in
or around the household. In collaboration with the University of Kentucky’s Veterinary
Diagnostic Lab in Lexington, Kentucky, we have investigated the prevalence of
Trypanosoma cruzi (the causative agent of Chagas disease) in canines from central and
eastern Kentucky via a serological test, polymerase chain reaction (PCR), and DNA
sequencing. In addition, Canine SNAP 4Dx plus tests (Idexx Laboratories, Inc.) were
used to determine the prevalence of four other vector-borne pathogens: Ehrlichia
canis/ewingii, Borrelia burgdorferi, Anaplasma phagocytophilum/platys, or Dirofilaria
immitis in the dogs. Results to date reveal a surprisingly high sero-prevalence of 10.23%
for T. cruzi. Two positive samples (2.27%) were confirmed using the polymerase chain
reaction and one resulted in a known T. cruzi sequence. In addition, results of the SNAP
4DX plus tests showed a prevalence of 5.68% for Ehrlichia canis/ewingii (the causative
agent of ehrlichiosis) and 6.82% for B. burgdorferi (the Lyme disease spirochete). We
believe that further studies are urgently needed to fully evaluate the role that canines
might be playing as reservoir hosts for these as well as other vector borne diseases in
Kentucky.
Keywords: Trypanosoma cruzi, Chagas disease, Canis lupus familiaris
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CHAPTER 1

INTRODUCTION

History:
Carlos Chagas, a Brazilian physician, was the first to discover Trypanosoma cruzi
(Chagas, 1909) while studying parasitic diseases in South America. Chagas observed
symptoms in patients that did not match any known disease. In his life, Chagas was able
to determine the clinical symptoms of infection, the epidemiology and life cycle of the
parasite within the vector and human host as well as other definitive hosts (Clayton,
2010). In honor of the extensive work Chagas put into the disease, it is now commonly
known as Chagas disease. It is also known as American trypanosomiasis due to the fact
that the etiological agent is a trypanosome that is endemic in North America, Central
America and South America.

Chagas disease in the United States:
Trypanosoma cruzi, the etiological agent of Chagas disease, is endemic to areas of
Mexico, Central America, and South America. However, recent studies have shown that
the parasite life cycle is also well established within the United States. As of 2009, the
estimated number of people with Trypanosoma cruzi infection within the United States
was 300,167 individuals (Bern et al., 2009). The majority of these cases occur in
individuals who have emigrated from Chagas endemic areas.
1

It is well known that canines can serve as crucial reservoir hosts in Latin America
(Gurtler et al., 1991). However, the role that dogs may be playing in the epidemiology of
Chagas disease in the United States is not well known (Beard et al., 2003). Trypanosoma
cruzi infection has been documented in the canine populations of Virginia, Oklahoma,
Tennessee, Louisiana, and Texas (Bradley et al., 2000; Burkholder et al., 1980; Kjos et
al., 2008; Rowland et al., 2010; Rosypal et al., 2010; Shadomy et al., 1980; Snider et al.,
1980; Williams et al., 1977; Meurs et al., 1998). Trypanosoma cruzi infection in the
domestic canine population implies that the vector is also likely present in the vicinity of
the human household.
Within the southeastern United States, there is evidence to support the presence of
a sylvatic cycle that involves the transmission of the parasite between Reduviid bugs and
wildlife reservoir hosts (Rosypal et al, 2007). There have been studies that show that wild
canids are also contracting Chagas disease. This is evident in the Rosypal et al., (2007)
study where 2 out of 26 gray foxes (8%) were T. cruzi positive out of South Carolina.
This shows that the cycle is perpetuated in the environment where canines are potentially
exposed.
It is assumed that canines are obtaining the infection by chewing the Reduviid
bug that is infected with T. cruzi. When infection is acquired, there is the possibility for a
dog to develop both acute and chronic Chagas disease. Mortality in the acute phase is
more common in very young dogs due to their inability to fight off the parasite. This
acute disease includes possible cardiomegaly and/or cardiac arrhythmias depending on
the strain of T. cruzi (Guedes et al., 2007, Kjos et al., 2008). Chronic disease commonly
manifests as heart disease in older canines which will ultimately lead to the death of the
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dog (Barr et al., 1991, Kjos et al., 2008). These symptoms are very similar to those that
occur within human populations. Unfortunately, at this time there are no approved
medications that veterinarians can use to combat this disease in canines.

Life Cycle of Trypanosoma cruzi:
Triatomine bugs in the insect family Reduviidae serve as intermediate hosts in the
life cycle of T. cruzi. Within the southeast this is predominately Triatoma sanguisuga
(Figure 1.1). The triatomine bug feeds on a potential host, typically a mammal, and
defecates on the skin as it takes its blood meal. The trypomastigote stages present in the
bug’s feces are introduced into the bite wound or enter via the mucous membrane of the
eyes, nose or mouth. Trypomastigotes enter host cells at the site of entry, and then rapidly
transform into amastigote stages. The amastigote stages then replicate through several
rounds of binary fission and then transform once again into trypomastigotes.
Trypomastigote stages erupt from the cells and disseminate to other cells and tissues.
Trypomastigotes circulating in the blood are also infective for the intermediate host, the
triatomine bug. The triatomine ingests the trypomastigotes along with the blood meal.
Within the mid-gut of the triatomine, the parasites transition into the epimastigote stage.
During this stage the epimastigotes proliferate in the gut before once again transforming
back to the trypomastigote stage in the hind gut. The trypomastigote stage is then
released when the triatomine bug defecates while consuming a blood meal. (CDC,
Roberts et al., 2012) (See Figure 1.2)

3

Figure 1.1: Triatoma Sanguisuga (retrieved from CDC.gov)

Figure 1.2: CDC Life cycle of Trypanosoma cruzi
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Other Vector Transmitted Diseases
There have been surprisingly few published studies that have investigated the
prevalence of tick-borne and other vector-borne pathogens within the canine population
within the state of Kentucky. These vector-borne pathogens include Borrelia burgdorferi,
Ehrlichia canis/ewingii, Anaplasma phagocytophilum/platys, and Dirofilaria immitis.
Borrelia burgdorferi, the causative agent of Lyme disease (Burgdorfer et al., 1982) and
Ehrlichia canis/ewingii, the causative agents of ehrlichiosis, are present in both human
and canine populations. Similar to T. cruzi, canines also serve as a reservoir host for these
diseases that are also communicable to human (Shaw et al., 2001).
The prevalence of Borrelia burgdorferi in Kentucky, according to a 2011 study of
287 ticks, is low, with only one tick (0.4%) confirmed to be positive for Borrelia
lonestari. This bacterial species causes a variant of Lyme disease known as southern tick
associated rash illness (STARI) (Fritzen et al., 2011). None of the ticks were carrying
Borrelia burgdorferi in that study. The prevalence of Ehrlichia ewingii, which was also
reported in this study, was 4 out of the 287 ticks (1.4%). In another study published in
2012, the prevalence of Ehrlichia ewingii in Kentucky was determined to be 3 out of 16
dogs and 1 out of 16 dogs for Ehrlichia canis (Beall et al., 2012).
Anaplasma phagocytophilum/platys, the causative agent of anaplasmosis in both
canines and humans, leads to the infection of the host’s neutrophils and neutrophil
precursors (Sarkar et al., 2007). In an unpublished study from our lab, the prevalence of
Anaplasma phagocytophilum/platys was 2 out of 361 domestic canines (0.53%). This
study was conducted on dogs from the western half of the state.

5

Dirofilaria immitis, the causative agent of canine heartworm, is transmitted
through a mosquito vector. In the same unpublished study from our laboratory, the
prevalence of Dirofilaria immitis in the western region of the state was determined to be
13 out of 361 dogs (3.7%).
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CHAPTER 2

MATERIALS AND METHODS

Canine sera: Serum or blood samples from domestic canines were obtained from
the University of Kentucky Veterinary Diagnostic lab and were transported back to
Western Kentucky University under refrigerated conditions. Upon arrival, a 250 microliter aliquot was removed from each sample, placed into a sterile microfuge tube, and
stored at a temperature of -20˚C. The collection vials containing the remaining sera or
blood samples were stored at 4˚C until use. Along with the serum samples, we recorded
the county of the reporting veterinarian, as well as the sex, age and breed of the canine.

Chagas dipstick chromatography test: Twenty micro-liters of sample canine
serum were applied to the dipstick’s sample pad and the end of the dipstick was placed
into one well of a 96-well, micro-liter plate. Three drops of chase buffer were then added
to the well. Additional buffer was added after one minute if the buffer had not yet
reached the test line. This additional buffer was typically one drop. After 10 minutes, the
results were read. The presence of a positive control line indicated that the test was
functioning properly, and the presence of a second test line was indicative of a positive
result; whereas no test line indicated a negative result. (See Figure 2.1)
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Figure 2.1: INBIOS dipstick example

SNAP 4Dx Plus Test (IDEXX):

After being allowed to equilibrate to room

temperature for 30 minutes, 3 drops of canine serum were added to a clean microfuge
tube. Four drops of the conjugate buffer were then added and the tube was inverted
several times to thoroughly mix the contents. The contents of the tube were then applied
to the sample well. Once the solvent front reached the activation window, the activator
pad was snapped down. Results were read after 8 minutes. The presence of a positive
control dot indicated that the test was functioning properly, and the presence of other dots
in specific locations indicated positive results for Ehrlichia canis/ewingii, B. burgdorferi,
Anaplasma phagocytophilum/platys, or Dirofilaria immitis respectively. (See Figure 2.2)
Some of the names are in red because they are the additional strains of the disease added
to the Snap test that distinguished between the Snap 4DX and the Snap 4DX Plus.

Figure 2.2: IDEXX Snap 4DX Plus Test Results
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DNA Isolation: Genomic DNA was isolated from 200 micro-liters of serum or
whole blood from each canine that gave a positive result on the Canine Chagas Dipstick
test. QIAamp DNA blood mini kits (Qiagen) were used for DNA isolation. DNA
concentrations were determined using a Nanodrop 2000 Spectrophotometer (Thermo
Scientific), and the DNA samples were stored at -20oC until use.

Polymerase Chain Reaction (PCR): PCR amplification was performed on
selected positive and negative DNA samples, using the TCZ1 and TCZ2 primer pair. The
TCZ1 and TCZ2 primers were designed to amplify 188 base pairs (bp) of a 195-bp
repetitive nuclear sequence of T. cruzi (Moser et al., 1989). The TCZ1 and TCZ2 primers
represent the following genomic sequences: TCZ1 (5’-CGA GCT CTT GCC CAC ACG
GGT GCT 3’) and TCZ2 (5’-CCT CCA AGC AGC GGA TAG TTC AGG 3’). Each
reaction mixture consisted of 20 micro-liters of the Master Mix, 1 micro-liter of the
TCZ1 primer, 1 micro-liter of the TCZ2 primer, 3 micro-liters of nanopure water, and 25
micro-liters of the canine template DNA. A negative control containing sterile nanopure
water in place of template DNA and a positive control sample of T. cruzi genomic DNA
were included with each analysis. Reaction mixtures were placed into an automated DNA
thermal cycler to undergo amplification as outlined in Figure 2.3.
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Figure 2.3. Thermocycler Protocol used for TCZ1 and TCZ2 primers.
Thermocycler program for PCR amplification using the TCZ1 and TCZ2 primers.
Temperature (°C)

Time

# of cycles

Initial Denature

94

2 min

1

Denature

94

1 min

30

Annealing

64.5

30 sec

Extension

72

15 sec

Final extension

72

5 min

1

Hold

4

Indefinite

1

Gel Electrophoresis: PCR products, as well as two 1-kb DNA ladders, were
loaded onto 2% agarose gels (containing GelRed) and subjected to electrophoresis at
100V for 1 hour. Gels were then taken to the Western Kentucky University
Biotechnology Center where images were captured using a Fluor Chem HD2 (Alpha
Innotech). These images were then saved permanently for later access.

DNA Sequence Analysis: A Big Dye Terminator v3.1 (Applied Biosystems)
sequencing reaction was performed on a subset of DNA samples determined to be
positive by PCR. Unincorporated dye terminators were removed from PCR amplification
products using a DyeX 2.0 Spin Kit (Qiagen), and samples were subjected to DNA
sequence analysis using an ABI 3130 Genetic Analyzer. The sequences were edited
before searching the BLAST database of the National Center for Biotechnology
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Information (NCBI) Genbank for sequence matches. These edits consisted of removing
the first 6-10 bases as well as the last 6-10 bases.
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CHAPTER 3

RESULTS

Trypanosoma cruzi:
A total of 88 serum samples, from 30 counties within the state of Kentucky, were
tested serologically for antibodies specific for the protozoan parasite, Trypanosoma cruzi.
The geographic distribution of positive samples by county is depicted in Figure 3.1 and
3.2. When analyzing the data that came with the T. cruzi positive serum samples, there
were some similarities. Four male and five female canines were sero-positive with an age
span ranging from 2.5 years to 8 years. Four of the positive samples were obtained from
four-year-old canines and two positive samples were collected from eight-year-old
canines. When analyzing the breeds of the canines that tested positive, the only similarity
found was that two of the positive canines were coonhounds.
The results of a recent collaboration with the Breathitt Veterinary Diagnostic Lab
in Hopkinsville Kentucky are shown in Figure 3.2 (unpublished results). Canine samples
from the Breathitt laboratory collaboration were obtained primarily from counties in
central and western Kentucky whereas canine samples analyzed in the present study were
obtained primarily from counties in central and eastern Kentucky.
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Figure 3.1: Geographic distribution by county of T. cruzi positive canine samples (UK
Diagnostic Lab Collaboration)

Figure 3.2: Geographic distribution by county of T. cruzi positive canine samples
(Breathitt Diagnostic Lab Collaboration)
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Figure 3.3: Positive T. cruzi Serological Dipsticks

DNA isolation
DNA was isolated from positive samples using a QIAamp DNA blood mini kit
(Qiagen) according to the manufacturer’s instructions. DNA concentrations (See Figure
3.4) were determined using a Nanodrop 2000 and samples were then frozen at -20C until
further use. Concentrations ranged from 0.7 ng/microliter to 6.3 ng/microliter.

14

Sample number
13

DNA concentration
(nanograms
/microliter)
1.2

15

1.1

25

0.7

32

1.0

38

6.3

72

2.3

77

3.5

82

3.6

83

3.9

Figure 3.4: DNA concentrations for T. cruzi positive canine serum samples

PCR and Agarose gel electrophoresis
DNA samples from sero-positive dogs were subjected to PCR using T. cruzispecific primers TCZ1 and TCZ2. Resulting products were then subjected to
electrophoresis. Two of the nine canine DNA samples were found to be PCR positive.
These canine samples were from Boyle and Grant County.

DNA Sequencing
The PCR products from two positive canine DNA samples were further subjected
to DNA sequencing analysis. One of the two samples resulted in a DNA sequence that
gave a positive match when blasted using the BLAST database of the National Center for
15

Biotechnology Information (NCBI) Genbank. The sequence showed 94% identity to the
known T. cruzi Can III satellite sequence (See Figure 3.6). The sequence was:

“CCGGTTTATGGGGTTGGAGGAAAAAGTTAACTATTACTTGCCGTTATCCAG
ATTTTTGCTGCGAATTGTGATGGTGGGAGTCAGAGGCACACTCTGTCACTACG
TGTCTGCGCGGTCACACACTGGTCACCAAACAACCCTGAACTATCCGCTGCTT
GGAGGAGG”

Figure 3.5: NCBI Blast results
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Figure 3.6: Comparing Sample 15 to CAN III satellite sequence

The canine that yielded this confirmed DNA sequence was from Boyle County. It
was a three-year-old, female, English bulldog. Although we did not perform strain
identification of the positive sequence, its match to the CAN III satellite sequence
indicates that is it may be a T. cruzi Type 4 strain (Figure 3.6).
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Other Vector borne diseases:
Eighty-eight canine serum samples from 30 counties were tested for Ehrlichia
canis/ewingii, Borrelia burgdorferi, Anaplasma phagocytophilum/platys, and Dirofilaria
immitis using Snap 4DX Plus tests.
Of the 88 samples, 6 tested positive for Borrelia burgdorferi, the causative agent
of Lyme disease (Figure 3.7). The gender of the Lyme positive canines was split evenly
with 50% being male and 50% being female. Three of the positive samples were from
Fayette County which includes the city of Lexington, Kentucky’s second largest city.
One other sample was from Jessamine, a county neighboring Fayette.
Five of the 88 canine serum samples tested positive for Ehrlichia canis/ewingii,
the causative agent of ehrlichiosis. (See Figure 3.8) None of the canines in this study
tested positive for canine heartworm (Dirofilaria immitis) or anaplasmosis (Anaplasma
phagocytophilum/platys).

Sample

County

Breed

Gender

Age

2

Laurel

mountain kurr

F

3

13

Whitley

fiest

F

3

41

Fayette

F

n/a

42

Fayette

M

7

65

N/a

n/a

M

2.5

83

Jessamine

mixed breed

M

8

Number

German
shepherd
doberman
pincher

Figure 3.7: Data for Borrelia burgdorferi positive canine samples
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Sample

County

Breed

Gender

Age

2

Laurel

mountain kurr

F

3

9

Marion

coonhound

M

5

14

Breckinridge

N/A

F

6

79

Washington

lab

F

3

86

Russell

Australian

M

4

Number

shepherd
Figure 3.8: Data for Ehrlichia canis/ewingii positive canine samples
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CHAPTER 4

DISCUSSION

The results of this study confirm the presence of Trypanosoma cruzi infection in
the domestic canine population of central and eastern Kentucky. Serological analysis of
the serum samples, showed a sero-prevalence of 10.23% (9/88). Two of the nine canine
samples were also found to be positive for T. cruzi by a highly sensitive PCR analysis.
One positive sample was confirmed to be T. cruzi based upon a 94% DNA sequence
identity to the satellite DNA sequence of the CAN III strain. The CAN III strain of T.
cruzi is known to be Type IV strain based upon serotype analysis. In an earlier
unpublished study conducted in collaboration with the Breathitt Veterinary Diagnostic
Research Laboratory, a sero-prevalence of 12.5% was observed from the central and
western half of the state. The overall sero-prevalence of Trypanosoma cruzi across the
state of Kentucky may be as high as 12.9% (58/449).
There have been many studies performed across the southeastern United States
that have documented the presence of T. cruzi infection in canine populations since 1972.
The prevalence of infection reported in these studies ranged- from a low of 1% in a
Virginia study, as reported by Rosypal et al. (2010), to as high as 22% in a Louisiana
study (Nieto et al., 2009). It should be noted that the Nieto et al. study in 2009 consisted
of only 50 dogs. The study performed by Rosypal et al. in 2010 had a sample size of 90
canines. The most recent study reporting sero-prevalence of canine Chagas was
20

conducted with shelter populations in Texas (Tenney et al., 2014). The sero-prevalence
reported in this study was 8.8% of 205 canines.
When comparing the eastern (Figure 3.1) and western (Figure 3.2) halves of
Kentucky to look for contradicting results, there were two counties that yielded different
results. Montgomery and Taylor counties both had sero-positive canine samples in the
Breathitt collaboration, but yielded sero-negative samples in the UK collaboration.
During the comparison; Jefferson, Mercer and Breckinridge County yielded exclusively
sero-negative samples in both studies. Within this study, no statistical comparisons were
performed between the two collaborations. The purpose of the current study was strictly
to investigate the prevalence of T. cruzi.
In the present study, PCR was used to confirm any serological positives because
the InBios assay is a serological test that strictly looks for antibodies to T. cruzi. The PCR
analysis is more sensitive and actually confirms the presence of T. cruzi DNA in canine
serum samples. It should be noted that none of the T. cruzi positive samples tested
positive for any of the other vector-borne pathogens looked at in this study. The TCZ1
and TCZ2 primers were used for the PCR analysis because these primers are specific for
185 base pairs of the highly repetitive 195 base pair sequence also known as the CAN III
satellite sequence (Moser et al. 1989). Due to the repetitiveness of CAN III Satellite
sequence, it allows for a much larger amplification of the DNA than if the primers were
only targeting a small portion of the T. cruzi genome. These primers are highly specific
and only target this DNA sequence while not replicating other DNA sequences that may
be present.
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Within our study, there was a difference between the number of serological
positives and those that were confirmed by PCR and then by DNA sequencing. This is
probably because samples consisted primarily of serum and not whole blood.
Consequently, the DNA yield was much smaller, which may have made it difficult to get
sufficient quantities of parasite DNA to amplify. Another possible explanation is that the
long-term storage of serum samples may have resulted in DNA degradation. By the time
the serum samples arrived in our lab, it may have been six weeks or more since the
samples were originally submitted to the diagnostic lab by veterinarians. One final
possibility is that some of the dogs may have been exposed to T. cruzi but did not develop
symptomatic Chagas disease.
It should be noted that all canines in this study were cared for by veterinarians in
central and eastern Kentucky. Most of the dogs in this study were likely to be on
preventatives for heartworm, if they went to a veterinarian on a regular basis, which
explains the lack of positive samples for the canine heartworm (Dirofilaria immitis). The
prevalence of Lyme disease on the Snap 4DX Plus tests may also not be a completely
accurate estimate of Lyme disease prevalence since the SNAP test is also an antibody
test, and does not confirm the presence of Borrelia burgdorferi.
Canine Chagas disease is currently not diagnosed by veterinarians in the state of
Kentucky. This diagnosis may not be occurring because either veterinarians aren’t aware
that the disease has reached Kentucky or because the majority of the canines are
asymptomatic. If there are no apparent symptoms, then there is no reason for a
veterinarian to submit blood work to the CDC or another diagnostic lab. The difficulty of
diagnosis is further compounded by the lack of a clinical serological test for Chagas
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disease to be used within veterinary clinics across the state. The InBios Canine Chagas
Dipstick was only approved for use in research, and it is now no longer available for
purchase due to the low demand. Finally, another reason for a lack of diagnosis is that
necropsies are rarely performed on canines. A necropsy is the only way to absolutely
confirm that a canine was infected by T. cruzi upon its death. Necropsies in the United
States are very expensive and are not usually requested by an owner when their pet dies
suddenly.
In conclusion, the results of this study demonstrate that dogs are being exposed to
Trypanosoma cruzi in Kentucky. Determining whether they are acquiring the actual
disease or just being exposed will require further studies. Veterinarians within the region
need to be notified that this parasitic disease is present in the state and that their patients
are at possible risk of infection. Future studies should be performed on canines found
within humane societies or shelters to survey canines that may not be actively cared for
by veterinarians their entire lives. Another future study that should be pursued based
upon the results of this study is to further investigate the higher prevalence of Lyme
disease in canines from eastern Kentucky.
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